Fiji Kava Limited (ASX:FIJ) is a health and wellness company with operations in Australia, Fiji and the USA. The company produces a range of natural products to reduce anxiety, promote relaxation, improve sleep and support sports recovery. These include dietary supplements and complementary medicines in solid dose forms, medicinal tinctures and teas, powdered drinks and functional beverages. Their products are marketed though major retail grocery and pharmacy chains, direct to consumers online and as bulk ingredients though B2B channels. Backed by years of independent research, Fiji Kava medical kava products are produced by high quality GMP and HACCP processes which are fully compliant with TGA and FDA requirements.
Fiji Kava Limited (ASX:FIJ) an Australian-Fijian medicinal Kava company which produces natural Noble Kava products for the natural medicine market, wishes to provide shareholders and investors with an overview of quarterly activities to accompany the Appendix 4C for the period ended 30 June 2022.
Fiji Kava Limited (ASX:FIJ) is pleased to announce the extension of the strategic partnership with Network Nutrition, a specialty ingredients brand which is part of the EUR8b Dutch publicly listed multinational, IMCD.
Fiji Kava Limited (ASX:FIJ) advises shareholders and investors that The Calmer Co. USA led by sales via Amazon direct to consumer and Danodan direct to consumer business units, now account for more than half of the Company s global revenue.
Fiji Kava Limited (ASX:FIJ), an Australian-Fijian medicinal Kava company which produces natural Noble Kava products for the natural medicine market, has entered a number of multi-year operational partnerships designed to streamline, vertically integrate, risk manage and expand the Company s supply chain in Fiji.